Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation

Innovative Medical

Status and phase: Completed; Phase 4

Conditions: Cataract; Dry Eye

Treatments: Drug: Topical Cyclosporine, Tears

Study type: Interventional

Funder types: Industry

Identifiers

NCT00349583

1683

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy on quality of vision and dry eye signs and symptoms in patients undergoing cataract surgery using the ReZoom® multifocal IOL.

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• · Males or females > 50 years old

  • Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL.
  • Likely to complete all study visits and able to provide informed consent
  • Visual potential of 20/25 or better

Exclusion criteria

• · Prior use of topical cyclosporine

  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease
  • Active ocular allergies